JAMA: "Telomerase Makes Old Cells Young Again"  http://jama.ama-assn.org/cgi/content/abstract/279/21/1732

CNN: "Scientists Discover Cellular Fountain of Youth" http://www.cnn.com/HEALTH/9801/13/life.extention/

SCIENCE: "Extension of Life-Span by Introduction of Telomerase" http://www.sciencemag.org/cgi/content/abstract/279/5349/349?ck=nck

CLONTECH: "Telomerase Immortalizes Cells Life-Span from 80 to 300" http://clontech.com/images/pt/dis_manuals/PT3358-1.pdf

SENESCENCE: "Anti-Aging Medicine" http://www.senescence.info/antiaging.html

BARNES AND NOBLE: "The Immortality Enzyme: Bionedical Breakthoughs You Can Use Against Aging..."  http://search.barnesandnoble.com/The-Immortality-Enzyme/Phillip-D-Minton/e/9781884367052

WELLNESS RESEARCH: "Anti-Aging Part-2" http://www.wellnessresearch.org/ha32.php

VIEWZONE: "Human Immortality: A Scientific Reality?"  http://www.viewzone.com/aging.html

ANTI-AGING TODAY: "The Telomerase Theory of Aging" http://www.anti-aging-today.org/aging/theory/telomerase.htm

 Other Releated Research Sources:

1 Hanahan, D., Weinberg, R.A. (2000) The hallmarks of cancer. Cell, 100, 57–70.

2 Shay, J.W., Wright, W.E. and Werbin, H. (1991) Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta, 1072, 1–7.

3 Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W. and Weinberg, R.A. (1999) Creation of human tumour cells with defined genetic elements. Nature, 499, 464–468.

4 Vogelstein, B. and Kinzler, K.W. (1993) The multistep nature of cancer. Trends Genet., 9, 138–141.

5 Wright, W.E. and Shay, J.W. (2000) Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nature Med., 6, 849–851.

6 Hayflick, L. and Moorhead, P.S. (1961) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res., 25, 585–621.

7 Shay, J.W. and Wright, W.E. (2000) Haylick, his limit, and cellular aging. Nature Rev. Mol. Cell. Biol., 1, 72–76.

8 Greider, C.W. (1998) Telomeres and senescence: the history, the experiment, the future. Curr. Biol., 8, 178–181.

9 Campisi, J. (1996) Replicative senescence—an old lives tale. Cell, 84, 497–500.

10 Wright, W.E. and Shay, J.W. (1992) The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol., 27, 383–389.

11 Harley, C.B. (1991) Telomere loss: mitotic clock or genetic time bomb? Mutat. Res., 256, 271–282.

12 Harley, C.B., Fletcher, A.B. and Greider, C.W. (1990) Telomeres shorten during aging. Nature, 345, 458–460.

13 Hastie, N.D., Dempster, M., Dunlop, M.G., Thompson, A.M., Green, D.K. and Allshire, R.C. (1990) Telomere reduction in human colorectal carcinoma and with aging. Nature, 346, 866–868.

14 deLange, T., Shiue, L., Myers, R.M., Cox, D.R., Naylor, S.L., Killery, A.M. and Varmus, H.E. (1990) Structure and variability of human chromosome ends. Mol. Cell. Biol., 10, 518–527.

15 Lindsey, J., McGill, N., Lindsey, L., Green, D. and Cooke, H. (1991) In vivo loss of telomeric repeats with age in humans. Mutat. Res., 256, 45–48.

16 Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley C.B. and Bacchetti, S. (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11, 1921–1929.

17 Wright, W.E., Brasiskyte, D., Piatyszek, M.A. and Shay, J.W. (1996) Experimental elongation of telomeres in immortal human cells extends the lifespan of immortal x normal cell hybrids. EMBO J., 15, 1734–1741.

18 Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.-P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S. and Wright, W.E. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science, 279, 349–352.

19 Vaziri, H. and Benchimol, S. (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol., 8, 279–282.

20 Halvorsen, T.L., Leibowitz, G. and Levine, F. (1999) Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol. Cell. Biol., 19, 1864–1870.

21 Moyzis, R.K., Buckingham, J.M., Cram, L.S., Dani, M., Deaven, L.L., Jones, M.D., Meyne, J., Ratliff, R.L. and Wu, J.-R. (1988) A highly conserved repetitive DNA sequence, (TTAGGG)_n, present at the telomeres of human chromosomes. Proc. Natl Acad. Sci. USA, 85, 6622–6626.

22 Blackburn, E.H. (2000) The end of the (DNA) line. Nature Struct. Biol., 7, 847–850.

23 Huffman, K.E., Levene, S.D., Tesmer, V.M., Shay, J.W. and Wright, W.E. (2000) Telomere shortening is proportional to the size of the 3' G-rich telomeric overhang. J. Biol. Chem., 275, 19719–19722.

24 Watson, J.D. (1972) Origin of concatameric T4 DNA. Nature, 239, 197–201.

25 Olovnikov, A.M. (1973) A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol., 41, 181–190.

26 Blackburn, E.H. (1992) Telomerases. Annu. Rev. Biochem., 61, 113–129.

27 Nugent, C.I. and Lundblad, V. (1998) The telomerase reverse transcriptase: components and regulation. Genes Dev., 12, 1073–1085.

28 Bryan, T.M. and Cech, T.R. (1999) Telomerase and the maintenance of chromosome ends. Curr. Opin. Cell Biol., 11, 318–324.

29 Greider, C.W. and Blackburn, E.H. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell, 43, 405–413.

30 Morin, G.B. (1989) The human telomerase terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59, 521–529.

31 Lingner, J., Hughes, T.R., Shevchenko, A., Mann, M., Lundblad, V. and Cech, T.R. (1997) Reverse transcriptase motifs in the catalytic subunit of telomerase. Science, 276, 561–567.

32 Nakamura, T.M., Morin, G.B., Chapman, K.B., Weinrich, S.L., Andrews, W.H., Lingner, J., Harley, C.B. and Cech, T.R. (1997) Telomerase catalytic subunit homologs from fission yeast and humans. Science, 277, 955–959.

33 Weinrich, S.L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V.M., Holt, S.E., Bodnar, A.G., Lichtsteiner, S., Kim, N.W., Trager, J.B. et al. (1997) Reconstitution of human telomerase with the catalytic protein subunit hTRT. Nature Genet., 17, 498–502.

34 Wright, W.E., Piatyszek, M.A., Rainey, W.E., Byrd, W. and Shay, J.W. (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet., 18, 173–179.

35 Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L. and Shay, J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011–2015.

36 Shay, J.W. and Bacchetti, S. (1997) A survey of telomerase activity in human cancer. Eur. J. Cancer, 33, 787–791.

37 Feng, J., Funk, W.D., Wang, S.S., Weinrich, S.L., Avilion, A.A., Chiu, C.-P., Adams, R.R., Chang, E., Allsopp, R.C., Yu, J.H. et al. (1995) The RNA component of human telomerase. Science, 269, 1236–1241.

38 Shay, J.W. and Wright, W.E. (1996) Telomerase activity in human cancer. Curr. Opin. Oncol., 8, 66–71.

39 Shay, J.W. and Wright, W.E. (1996) The reactivation of telomerase activity in cancer progression. Trends Genet., 12, 129–131.

40 Holt, S.E. and Shay, J.W. (1999) Role of telomerase in cellular proliferation and cancer. J. Cell Physiol., 180, 10–18.

41 Wright, W.E. and Shay, J.W. (2001) Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet. Dev., 11, 98–103.

42 Shay, J.W. (1995) Aging and cancer: are telomeres and telomerase the connection? Mol. Med. Today, 1, 378–384.

43 Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S. and Reddel, R.R. (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J., 14, 4240–4248.

44 Lansdorp, P.M., Verwoerd, N.P., Vanderijke, F.M., Dragowska, V., Little, M.T., Dirks, R.W., Raap, A.L. and Tanke, H.J. (1996) Heterogeneity in telomere length of human chromosomes. Hum. Mol. Genet., 5, 685–691.

45 Allsopp, R.C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E.V., Futcher, A.B., Greider, C.W. and Harley, C.B. (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl Acad. Sci. USA, 89, 10114–10118.

46 Jiang, X.R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A.G., Wahl, G.M., Tlsty, T.D. and Chiu, C.-P. (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nature Genet., 21, 111–114.

47 Morales, C.P., Holt, S.E., Ouellette, M., Kaur, K.J., Yan, Y., Wilson, K.S., White, M.A., Wright, W.E. and Shay, J.W. (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genet., 21, 115–118.

48 Counter, C.M., Hahn, W.C., Wei, W., Caddle, S.D., Beijersbergen, R.L., Lansdorp, P.M., Sedivy, J.M. and Weinberg, R.A. (1998) Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl Acad. Sci. USA, 95, 14723–14728.

49 Ouellette, M.M., McDaniel, L.D., Wright, W.E., Shay, J.W. and Schultz, R.A. (2000) The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. Hum. Mol. Genet., 9, 403–411.

50 Yang, J., Chang, E., Cherry, A.M., Bangs, C.D., Oei, Y., Bodnar, A., Bronstein, A., Chiu, C.-P. and Herron, G.S. (1999) Human endothelial cell life extension by telomerase expression. J. Biol. Chem., 274, 26141–26148.

51 Thomas, M., Yang, L. and Hornsby, P.J. (2000) Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase. Nature Biotechnol., 18, 39–42.

52 Shay, J.W. and Wright, W.E. (2000) The use of telomerized cells for tissue engineering. Nature Biotechnol., 18, 22–23.

53 Wyllie, F.S., Jones, C.J., Skinner, J.W., Haughton, M.F., Wallis, C., Wynford-Thomas, D., Faragher, R.G. and Kipling, D. (2000) Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nature Genet., 24, 16–17.

54 Zhu, J., Wang, H., Bishop, J.M. and Blackburn, E.H. (1999) Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl Acad. Sci. USA, 96, 3723–3728.

55 Chong, L., van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P. and de Lange, T. (1995) A human telomeric protein. Science, 270, 1663–1667.

56 Broccoli, D., Smogorzewska, A., Chong, L. and de Lange, T. (1997) Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nature Genet., 17, 231–235.

57 van Steensel, B., Smogorzewska, A. and de Lange, T. (1998) TRF2 protects human telomeres from end-to-end fusions. Cell, 92, 401–413.

58 van Steensel, B. and de Lange, T. (1997) Control of telomere length by the human telomeric protein TRF1. Nature, 385, 740–743.

59 Smogorzewska, A., Van Steensel, B., Bianchi, A., Oelmann, S., Schaefer, M.R., Schnapp, G. and de Lange, T. (2000) Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol., 20, 1659–1668.

60 Bianchi, A., Stansel, R.M., Fairall, L., Griffith, J.D., Rhodes, D. and de Lange, T. (1999) TRF1 binds a bipartite telomeric site with extreme spatial flexibility. EMBO J., 18, 5735–5744.

61 Shay, J.W. (1999) At the end of the millennium a view of the end. Nature Genet., 23, 382–383.

62 Greider, C.W. (1996) Telomere length regulation. Annu. Rev. Biochem., 65, 337–365.

63 Smith, S., Giriat, I., Schmitt, A. and de Lange, T. (1998) Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science, 282, 1484–1487.

64 Smith, S. and de Lange, T. (2000) Tankyrase promotes telomere elongation in human cells. Curr. Biol., 10, 1299–1302.

64 Bilaud, T., Brun, C., Ancelin, K., Koering, C.E., Laroche, T. and Gilson, E. (1997) Telomeric localization of TRF2, a novel human telobox protein. Nature Genet., 17, 236–239.

65 Smith, S. and de Lange, T. (1999) Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes. J. Cell Sci., 112, 3649–3656.

66 Kim, S.H., Kaminker, P. and Campisi, J. (1999) TIN2, a new regulator of telomere length in human cells. Nature Genet., 23, 405–412.

67 Li, B.B., Oestreich, S. and de Lange, T. (2000) Identification of human Rap1: Implications for telomere evolution. Cell, 101, 471–483.

68 Zhu, X.D., Kuster, B., Mann, M., Petrini, J.H.J. and de Lange, T. (2000) Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nature Genet., 25, 347–352.

69 Bianchi, A. and de Lange, T. (1999) Ku binds telomeric DNA in vitro. J. Biol. Chem., 274, 21223–21227.

70 Hsu, H.L., Gilley, D., Galande, S.A., Hande, M.P., Allen, B., Kim, S.H., Li, G.C., Campisi, J., Kohwi-Shigematsu, T. and Chen, D.J. (2000) Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev., 14, 2807–2812.

71 McKay, S.J. and Cooke, H. (1992) hnRNP A2/B1 binds specifically to single stranded vertebrate telomeric repeat TTAGGG_n. Nucleic Acids Res., 20, 6461–6464.

72 LaBranche, H., Dupuis, S., Ben-David, Y., Bani, M.R., Wellinger, R.J. and Chabot, B. (1998) Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nature Genet., 19, 199–202.

73 Eversole, A. and Maizels, N. (2000) In vitro properties of the conserved mammalian protein hnRNP D suggest a role in telomere maintenance. Mol. Cell. Biol., 20, 5425–5432.

74 Dallaire, F., Dupuis, S., Fiset, S. and Chabot, B. (2000) Heterogeneous nuclear ribonucleoprotein A1 and UP1 protect mammalian telomeric repeats and modulate telomere replication in vitro. J. Biol. Chem., 275, 14509–14516.

75 Smilenov, L.B., Morgan, S.E., Mellado, W., Sawant, S.G., Kastan, M.B. and Pandita, T.K. (1997) Influence of ATM function on telomere metabolism. Oncogene, 15, 2659–2666.

76 Smilenov, L.B., Dhar, S. and Pandita, T.K. (1999) Altered telomere nuclear matrix interactions and nucleosomal periodicity in cells derived from individuals with ataxia telangiectasia before and after ionizing radiation treatment. Mol. Cell. Biol., 19, 6963–6971.

77 Wood, L.D., Halvorsen, T.L., Dhar, S., Baur, J.A., Pandita, R.K., Wright, W.E., Hande, M.P., Calaf, G., Levine, F., Shay, J.W. et al. (2001) Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression. Oncogene, 20, 278–288.

78 di Fagagna, F.D., Hande, M.P., Tong, W.M., Lansdorp, P.M., Wang, Z.Q. and Jackson, S.P. (1999) Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nature Genet., 23, 76–80.

79 Griffith, J.D., Comeau, L., Rosenfield, S., Stansel, R.M., Bianchi, A., Moss, H. and de Lange, T. (1999) Mammalian telomeres end in a large duplex loop. Cell, 97, 503–514.

80 Mitchell, J.R., Cheng, J. and Collins, K. (1999) A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end. Mol. Cell. Biol., 19, 567–576.

81 Chen, J.L., Blasco, M.A. and Greider, C.W. (2000) Secondary structure of vertebrate telomerase RNA. Cell, 100, 503–514.

82 Narayanan, A., Lukowiak, A., Jady, B.E., Dragon, F., Kiss, T., Terns, R.M. and Terns, M.P. (1999) Nucleolar localization signals of Box H/ACA small nucleolar RNAs. EMBO J., 18, 5120–5130.

83 Greider, C.W. and Blackburn, E.H. (1987) The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell, 51, 887–898.

84 Gilley, D. and Blackburn, E.H. (1999) The telomerase RNA pseudoknot is critical for the stable assembly of a catalytically active ribonucleoprotein. Proc. Natl Acad. Sci. USA, 96, 6621–6625.

85 Ford, L.P., Myoung, J., Wright, W.E. and Shay, J.W. (2000) Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with human telomerase. Mol. Cell. Biol., 20, 9084–9091.

86 Bryan, T.M., Goodrich, K.J. and Cech, T.R. (2000) Telomerase RNA bound by protein motifs specific to telomerase reverse transcriptase. Mol. Cell, 6, 493–499.

87 Mitchell, J.R. and Collins, K. (2000) Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase. Mol. Cell, 6, 361–371.

88 Tesmer, V.M., Ford, L.P., Holt, S.E., Frank, B.C., Yi, X., Aisner, D.L., Ouellette, M., Shay, J.W. and Wright, W.E. (1999) Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro. Mol. Cell. Biol., 19, 6207–6216.

89 Johnston, S.D., Lew, J.E. and Berman, J. (1999) Gbp1p, a protein with RNA recognition motifs, binds single-stranded telomeric DNA and changes its binding specificity upon dimerization. Mol. Cell. Biol., 19, 923–933.

90 Shay, J.W. and Wright, W.E. (1999) Mutant dyskerin ends relationship with telomerase. Science, 286, 2284–2285.

91 Mitchell, J.R., Wood, E. and Collins, K. (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature, 402, 551–555.

92 Le, S., Sternglanz, R. and Greider, C.W. (2000) Identification of two RNA-binding proteins associated with human telomerase RNA. Mol. Biol. Cell, 11, 999–1010.

93 Harrington, L., McPhail, T., Mar, V., Zhou, W., Oulton, R., Bass, M.B., Arruda, I. and Robinson, M.O. (1997) A mammalian telomerase-associated protein. Science, 275, 973–977.

94 Kickhoefer, V.A., Stephen, A.G., Harrington, L., Robinson, M.O. and Rome, L.H. (1999) Vaults and telomerase share a common subunit, TEP1. J. Biol. Chem., 274, 32712–32717.

95 Dragon, F., Pogacic, V. and Filipowicz, W. (2000) In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol. Cell. Biol., 20, 3037–3048.

96 Holt, S.E., Aisner, D.L., Baur, J., Tesmer, V.M., Dy, M., Ouellette, M., Trager, J.B., Morin, G.B., Toft, D.O., Shay, J.W. et al. (1999) Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev., 13, 817–826.

97 Dallaire, F., Dupuis, S., Fiset, S. and Chabot, B. (2000) Heterogeneous nuclear ribonucleoprotein A1 and UP1 protect mammalian telomeric repeats and modulate telomere replication in vitro. J. Biol. Chem., 275, 14509–14516.

98 Ishikawa, F., Matunis, M.J., Dreyfuss, G. and Cech, T.R. (1993) Nuclear proteins that bind the pre-mRNA 3' splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)_n. Mol. Cell. Biol., 13, 4301–4310.

99 Ford, L.P., Shay, J.W. and Wright, W.E. (2001) The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo. RNA, in press.

100 Pannone, B.K., Xue, D. and Wolin, S.L. (1998) A role for the yeast La protein in U6 snRNP assembly: evidence that the La protein is a molecular chaperone for RNA polymerase III transcripts. EMBO J., 17, 7442–7453.

101 Kufel, J., Allmang, C., Chanfreau, G., Petfalski, E., Lafontaine, D.L. and Tollervey, D. (2000) Precursors to the U3 small nucleolar RNA lack small nucleolar RNP proteins but are stabilized by La binding. Mol. Cell. Biol., 20, 5415–5424.

102 Van Horn, D.J., Yoo, C.J., Xue, D., Shi, H. and Wolin, S.L. (1997) The La protein in Schizosaccharomyces pombe: a conserved yet dispensable phosphoprotein that functions in tRNA maturation. RNA, 3, 1434–1443.

103 Breslow, R.A., Shay, J.W., Gazdar, A.F. and Srivastava. S. (1997) Telomerase and early detection of cancer: a national cancer institute workshop. J. Natl Cancer Inst., 89, 618–623.

104 Shay, J.W. (1998) Telomerase in cancer: diagnostic, prognostic and therapeutic implications. Cancer J. Sci. Am., 4 (suppl. 1), S26–S34.

105 Shay, J.W., Brasiskyte, D., Ouellete, M., Piatyszek, M.A., Werbin, H., Ying, Y. and Wright, W.E. (1994) Methods for analysis of telomerase and telomeres. In Adolph, K.W. (ed.), Methods in Molecular Genetics, Vol. 5. Academic Press, San Diego, CA, pp. 263–280.

106 Piatyszek, M.A., Kim, N.W., Weinrich, S.L., Hiyama, K., Hiyama, E., Wright, W.E. and Shay, J.W. (1995) Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci., 17, 1–15.

107 Holt, S.E., Norton, J.C., Wright, W.E. and Shay, J.W. (1996) Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sci., 18, 237–248.

108 Wright, W.E., Shay, J.W. and Piatyszek, M.A.(1995) Modification of a telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity and sensitivity. Nucleic Acids Res., 23, 3794–3795.

109 Ohyashiki, J.H, Ohyashiki, K., Toyama, K. and Shay, J.W. (1996) A non-radioactive fluorescence-based telomeric repeat amplification protocol to detect and quantitate telomerase activity. Trends Genet., 12, 395–396.

110 Ohyashiki, K., Ohyashiki, J., Nishimaki, J., Toyama, K., Ebihara, Y., Wright, W.E. and Shay, J.W. (1997) Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res., 57, 2100–2103.

111 Norton, J.C., Gollahon, L.S., Holt, S.E., Wright, W.E. and Shay, J.W. (1998) Enhanced detection of telomerase activity in tumor derived human cell lines. DNA Cell Biol., 17, 217–219.

112 Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A.F., Piatyszek, M.A. and Shay, J.W. (1995) Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl Cancer Inst., 87, 895–902.

113 Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M.A. and Shay, J.W. (1995) Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med., 1, 249–257.

114 Langford, L.A., Piatyszek, M.A., Xu, R., Schold, S.C. and Shay, J.W. (1995) Telomerase activity in human brain tumors. Lancet, 346, 1267–1268.

115 Sommerfeld, H.-J., Meeker, A.K., Piatyszek, M.A., Bova, G.S., Shay, J.W. and Coffey, D.S. (1996) Telomerase activity: A prevalent marker of malignant human prostate tissue. Cancer Res., 56, 218–222.

116 Hiyama, E., Gollahon, L., Kataoka, T., Kutoi, K., Yokoyama, T., Gazdar, A.F., Hiyama, K., Piatyszek, M.A. and Shay, J.W. (1996) Telomerase activity in human breast tumors. J. Natl Cancer Inst., 88, 116–122.

117 Avilion, A.A., Piatyszek, M.A., Gupta, J., Shay, J.W., Bacchetti, S. and Greider, C.W. (1996) Human telomerase RNA levels in immortal cell lines and tumor tissues. Cancer Res., 56, 645–650.

118 Taylor, R.S., Ramirez, R.D., Ogoshi, M., Chaffins, M., Piatyzsek, M.A. and Shay, J.W. (1996) Telomerase activity in malignant and nonmalignant skin conditions. J. Invest. Dermatol., 106, 759–765.

119 Mehle, C., Piatyszek, M.A., Ljungberg, B., Shay, J.W. and Roos, G. (1996) Telomerase activity in human renal cell carcinoma. Oncogene, 13, 161–166.

120 Shay, J.W., Werbin, H. and Wright, W.E. (1996) Telomeres and telomerase in human leukemias. Leukemia, 10, 1255–1261.

121 Hiyama, E., Kodama, T., Shimbara, K., Ito, M., Hiyama, K., Shay, J.W., Matsuura, Y. and Yokoyama, T. (1997) Telomerase activity is detected in pancreatic cancer but not in benign pancreatic lesions. Cancer Res., 57, 326–331.

122 Yashima, K., Piatyszek, M.A., Saboorian, H.M., Virmani, A.K., Brown, D., Shay, J.W. and Gazdar, A.F. (1997) Expression of telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J. Clin. Pathol., 50, 110–117.

123 Ohyashiki, J.H., Ohyashiki, K., Iwama, H., Hayashi, S., Toyama, K. and Shay, J.W. (1997) Clinical implications of telomerase activity levels in acute leukemia. Clin. Cancer Res., 3, 619–625.

124 Muller, M., Krause, H., Heicappell, R., Tischendorf, J., Shay, J.W. and Miller, K. (1998) Detection of human telomerase RNA (hTR) and telomerase activity in urine for diagnosis of bladder cancer. Clin. Cancer Res., 4, 1949–1954.

125 Yashima, K., Milchgrub, S., Gollahon, L., Maitra, A., Saboorian, H., Shay, J.W. and Gazdar, A.F. (1998) Telomerase expression during multistage pathogenesis of breast carcinoma. Clin. Cancer Res., 4, 229–234.

126 Yashima, K., Maitra, A., Timmons, C.F., Rogers, B.B., Pinar, H., Shay, J.W. and Gazdar, A.F. (1998) Expression of the RNA component of telomerase in Wilm’s tumor and its precursor lesion recapitulates renal embryogenesis. Hum. Pathol., 28, 536–542.

127 Yashima, K., Ashfaq, R., Nowak, J., Von Gruenigen, V., Milchgrub, S., Rathi, A., Albores-Saavedra, J., Shay, J.W. and Gazdar, A.F. (1998) Telomerase activity and expression of its RNA component in cervical lesions. Cancer, 82, 1319–1327.

128 Morales, C.P., Lee, E.L. and Shay, J.W. (1998) In situ hybridization for the detection of telomerase RNA in the progression from Barrett’s esophagus to esophageal adenocarcinoma. Cancer, 83, 652–659.

129 Ramirez, R.D., D’Atri, S., Pagani, E., Faraggiana, T., Lacal, P.M., Taylor, R.S. and Shay, J.W. (1999) Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia, 1, 42–49.

130 Tatsumoto, N., Hiyama, E., Murakami, Y., Imamura, Y., Shay, J.W., Matsuura, Y. and Yokoyama, T. (2000) High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin. Cancer Res., 6, 2696–2701.

131 Hiyama, E., Saeki, T., Hiyama, K., Takashima, S., Shay, J.W., Matsuura, Y. and Yokayama, T. (2000) Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples. Cancer, 90, 235–238.

132 Hiyama, E., Hiyama, K., Yokoyama, T. and Shay, J.W. (2001) Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia, 3, 17–26.

133 Shay, J.W. and Gazdar, A.F. (1997) Telomerase in the early detection of cancer. J. Clin. Pathol., 50, 106–109.

134 Herbert, B.-S., Pitts, A.E., Baker, S.I., Hamilton, S.E., Wright, W.E., Shay, J.W. and Corey, D.R. (1999) Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl Acad. Sci. USA, 96, 14276–14281.

135 Herbert, B.-S., Wright, A.C., Passons, C.M., Ali, I., Wright, W.E., Kopelovich, L. and Shay, J.W. (2001) Inhibition of the spontaneous immortalization of breast epithelial cells from individuals predisposed to breast cancer: Effects of chemopreventive and anti-telomerase agents. J. Natl Cancer Inst., 93, 39–45.

136 Norton, J.C., Piatyszek, M.A., Wright, W.E., Shay, J.W. and Corey, D.R (1996) Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotechnol., 14, 615–619.

137 Shammas, M.A., Simmons, C.G., Corey, D.R. and Schmooker Reis, R.J. (1999) Telomerase inhibition by peptide nucleic acids reverses ‘immortality’ of transformed human cells. Oncogene, 18, 6191–6200.

138 Faraoni, I., Turriziana, M., Giovanna, M., deVecchis, L., Bonmassar, E., Shay, J.W. and Graziani, G. (1997) Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro. Clin. Cancer Res., 3, 579–585.

139 de Lange, T. and Jacks, T. (1999) For better or worse? Telomerase inhibition and cancer. Cell, 98, 273–275.

140 McKenzie, K.E., Umbricht, C.B. and Sukumar, S. (1999) Applications of telomerase research in the fight against cancer. Mol. Med. Today, 5, 114–122.

141 White, L., Wright, W.E. and Shay, J.W. (2001) Telomerase inhibitors. Trends Biotechnol., 19, 114–120.

142 Hamilton, S.E., Simmons, C.G., Kathriya, I. and Corey, D.R. (1999). Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem. Biol., 6, 343–351.

143 Corey, D.R. (2000) Telomerase: An unusual target for cytotoxic agents. Chem. Res. Toxicol., 13, 957–960.

144 Paull, K.D., Shoemaker, R.H., Hodes, L., Monks, A., Scudiero, D.A., Rubinstein, L., Plowman, J. and Boyd, M.K. (1989) Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J. Natl Cancer Inst., 81, 1088–1092.

145 Naasani, I., Seimiya, H., Yamori, T. and Tsuruo, T. (1999) FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Res., 59, 4004–4011.

146 Vonderheide, R.H., Hahn, W.C., Schultze, J.L. and Nadler, L.M. (1999) The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity, 10, 673–679.

147 Minev, B., Hipp, J., Firat, H., Schmidt, J.D., Langlade-Demoyen, P. and Zanetti, M. (2000) Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc. Natl Acad. Sci. USA, 97, 4796–4801.

148 Rosenberg, S.A., Yang, J.C., Schwartzentruber, D.J., Hwu, P., Marincola, F.M., Topalian, S.L., Restifo, N.P., Dudley, M.E., Schwarz, S.L., Spiess, P.J. et al. (1998) Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature Med., 4, 321–327.

149 Zhang, X., Mar, V., Zhou, W., Harrington, L. and Robinson, M.O. (1999) Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev., 13, 2388–2399.

150 Hahn, W.C., Stewart, S.A., Brooks, M.W., York, S.G., Eaton, E., Kurachi, A., Beijersbergen, R.L., Knoll, J.H., Meyerson, M. and Weinberg, R.A. (1999) Inhibition of telomerase limits the growth of human cancer cells. Nature Med., 5, 1164–1170.

151 Shay, J.W. (1999) Toward identifying a cellular determinant of telomerase repression. J. Natl Cancer Inst., 91, 4–6.

152 Galderisi, U., Cascino, A. and Giordanoa, A. (1999) Antisense oligonucleotides as therapeutic agents. J. Cell Physiol., 181, 251–257.

153 Ohnuma, T., Zimnik, D.V., Gordeev, S.A. and Severin, S.E. (1997) Inhibitory effects of telomere-mimic phosphorotioate oligonucleotides on various human tumor cells in vitro. Anticancer Res., 17, 2455–2458.

154 Glukhov, A.I., Chakerian, A.E., Fore, M.L., Bryant, J.E., Hernandez, J.P., Moyzis, R.K. and Griffith, J.K. (1998) Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotide. Biochem. Biophys. Res. Commun., 248, 368–371.

155 Mata, J.E., Joshi, S.S., Palen, B., Pirruccello, S.J., Jackson, J.D., Elias, N., Page, T.J., Medlin, K.L. and Iversen, P.L. (1997) A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt’s lymphoma cells in vitro and in vivo. Toxicol. Appl. Pharmacol., 144, 189–197.

156 Kondo, S., Kondo, Y., Li, G., Silverman, R.H. and Cowell, J.K. (1998) Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene, 16, 3323–3330.

157 Kushner, D.M., Paranjape, J.M., Bandyopadnyay, M.S., Cramer, H., Leaman, D.W., Kennedy, A.W., Silverman, R.H. and Cowell, J.K. (2000) 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells. Gynecol. Oncol., 76, 183–192.

158 Kondo, Y., Koga, S., Komata, T. and Kondo, S. (2000) Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component. Oncogene, 19, 2205–2211.

159 Yokoyama, Y., Takahashi, Y., Shinohara, A., Lian, Z., Wan, X., Niwa, K. and Tamaya, T. (1998) Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res., 58, 5406–5410.

160 Folini, M., Colella, G., Villa, R., Lualdi, S., Daidone, G. and Zaffaroni, N. (2000) Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells. J. Invest. Dermatol., 114, 259–267.

161 Zhang, X., Mar, V., Zhou, W., Harrington, L. and Robinson, M.O. (1999) Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev., 13, 2388–2399.

162 Strahl, C. and Blackburn, E.H. (1996) Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortal human cell lines. Mol. Cell. Biol., 16, 53–56.

163 Melana, S.M., Holland, J.F. and Pogo, B.G.-T. (1997) Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. Clin. Cancer Res., 4, 693–696.

164 Murakami, J., Nagai, N., Shigemasa, K. and Ohama, K. (1998) Inhibition of telomerase activity and cell proliferation by a reverse transcriptase inhibitor in gynaecological cancer cell lines. Eur. J. Cancer, 35, 1027–1034.

165 Gomez, D.E., Tejera, A.M. and Olivera, O.A. (1998) Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment. Biochem. Biophys. Res. Commun., 246, 107–110.

166 Harrison, R.J., Gowan, S.M., Kelland, L.R. and Neidles, S. (1999) Human telomerase inhibition by substituted acridine derivatives. Bioorg. Med. Chem., 9, 2463–2468.

167 Sun, D., Thompson, B., Cathers, B.E., Salazar, M., Kerwin, S.M., Trent, J.O., Jenkins, T.C., Neidle, S. and Hurley, L.M. (1997) Inhibition of human telomerase by a G-quadruplex-interactive compound. J. Med. Chem., 40, 2113–2116.

168 Perry, P.J., Read, M.A., Davies, R.T., Gowan, S.M., Reska, A.P., Wood, A.A., Kelland, L.R. and Neidle, S. (1999) 2,7-disubstituted amidofluorenone derivatives as inhibitors of human telomerase. J. Med. Chem., 42, 2679–2684.

169 Read, M.A., Wood, A.A, Harrison, J.R., Gowan, S., Kelland, S.R., Doganjh, H.S and Neidle, S. (1999) Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure–activity relationships. J. Med. Chem., 42, 4538–4546.

© 2010 Reneuve LLC.  All Rights Reserved 

 © 2010 Reneuve LLC.  All Rights Reserved